2003
DOI: 10.1016/s1388-2457(03)00034-8
|View full text |Cite
|
Sign up to set email alerts
|

Transcranial magnetic stimulation (TMS) of the sensorimotor cortex and medial frontal cortex modifies human pain perception

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
69
0
2

Year Published

2004
2004
2016
2016

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 87 publications
(75 citation statements)
references
References 47 publications
4
69
0
2
Order By: Relevance
“…The stimulation location corresponding to SII was localised 2.5 cm anterior and 6.5 cm superior to the preauricular point, in accord with previous TMS studies [Harris et al, 2002;Kanda et al, 2003]. Finally, the stimulation location corresponding to VI was 2 cm dorsal and 0.6 cm lateral to the calcarine sulcus, which corresponds to the primary visual cortex Fernandez et al, 2002].…”
Section: Figuresupporting
confidence: 84%
“…The stimulation location corresponding to SII was localised 2.5 cm anterior and 6.5 cm superior to the preauricular point, in accord with previous TMS studies [Harris et al, 2002;Kanda et al, 2003]. Finally, the stimulation location corresponding to VI was 2 cm dorsal and 0.6 cm lateral to the calcarine sulcus, which corresponds to the primary visual cortex Fernandez et al, 2002].…”
Section: Figuresupporting
confidence: 84%
“…However, in a very recent TMS study, double-pulse stimulation over the frontal cortex has been 0022-510X/$ -see front matter D 2004 Elsevier B.V. All rights reserved. doi:10.1016/j.jns.2004.08.008 demonstrated to transitorily suppress the central processing of pain perception, increasing threshold to pain stimuli [12].…”
Section: Introductionmentioning
confidence: 99%
“…The TMS head coil (manufactured by Neotonus, Inc., Marietta, GA, USA) was placed at the midline anteriorly on the patient's scalp. This placement was intended to maximize stimulation of the medial prefrontal area that overlays the anterior cingulate region, which has been implicated in depression and central pain syndromes [11,12].…”
Section: Resultsmentioning
confidence: 99%
“…HBOT is believed to have anti-inflammatory effects, reducing the excess of proinflammatory cytokine activation such as TNF-alpha and facilitating improvement by provocation of stem cell activity [7][8][9][10]. The combination therapy of infused ketamine administered concurrent to TMS appears to address the abnormalities in brain circuits found both in treatment resistant depression and treatment resistant central pain [11][12][13][14][15][16]. Additionally, ketamine is known to act as a TNF-alpha inhibitor, thus favoring an anti-inflammatory effect [17].…”
Section: Introductionmentioning
confidence: 99%